Literature DB >> 32820060

Designed protein logic to target cells with precise combinations of surface antigens.

Marc J Lajoie1,2, Scott E Boyken3,2, Alexander I Salter4,5, Jilliane Bruffey3,2,6, Anusha Rajan4,5, Robert A Langan3,2, Audrey Olshefsky3,7, Vishaka Muhunthan4,5, Matthew J Bick3,2, Mesfin Gewe5, Alfredo Quijano-Rubio3,2,7, JayLee Johnson3, Garreck Lenz3, Alisha Nguyen3, Suzie Pun7,8, Colin E Correnti5, Stanley R Riddell4,5,9, David Baker1,2,10.   

Abstract

Precise cell targeting is challenging because most mammalian cell types lack a single surface marker that distinguishes them from other cells. A solution would be to target cells using specific combinations of proteins present on their surfaces. In this study, we design colocalization-dependent protein switches (Co-LOCKR) that perform AND, OR, and NOT Boolean logic operations. These switches activate through a conformational change only when all conditions are met, generating rapid, transcription-independent responses at single-cell resolution within complex cell populations. We implement AND gates to redirect T cell specificity against tumor cells expressing two surface antigens while avoiding off-target recognition of single-antigen cells, and three-input switches that add NOT or OR logic to avoid or include cells expressing a third antigen. Thus, de novo designed proteins can perform computations on the surface of cells, integrating multiple distinct binding interactions into a single output.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32820060      PMCID: PMC8085813          DOI: 10.1126/science.aba6527

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Chemical synthesis of the mouse mitochondrial genome.

Authors:  Daniel G Gibson; Hamilton O Smith; Clyde A Hutchison; J Craig Venter; Chuck Merryman
Journal:  Nat Methods       Date:  2010-10-10       Impact factor: 28.547

2.  α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.

Authors:  James W Checco; Erinna F Lee; Marco Evangelista; Nerida J Sleebs; Kelly Rogers; Anne Pettikiriarachchi; Nadia J Kershaw; Geoffrey A Eddinger; David G Belair; Julia L Wilson; Chelcie H Eller; Ronald T Raines; William L Murphy; Brian J Smith; Samuel H Gellman; W Douglas Fairlie
Journal:  J Am Chem Soc       Date:  2015-08-28       Impact factor: 15.419

3.  4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies.

Authors:  Syam Tammana; Xin Huang; Marianna Wong; Michael C Milone; Linan Ma; Bruce L Levine; Carl H June; John E Wagner; Bruce R Blazar; Xianzheng Zhou
Journal:  Hum Gene Ther       Date:  2010-01       Impact factor: 5.695

4.  Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.

Authors:  Shivani Srivastava; Alexander I Salter; Denny Liggitt; Sushma Yechan-Gunja; Megha Sarvothama; Kirsten Cooper; Kimberly S Smythe; Jarrod A Dudakov; Robert H Pierce; Christoph Rader; Stanley R Riddell
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

5.  A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

Authors:  Xiuli Wang; Wen-Chung Chang; ChingLam W Wong; David Colcher; Mark Sherman; Julie R Ostberg; Stephen J Forman; Stanley R Riddell; Michael C Jensen
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

6.  ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules.

Authors:  Andrew Leaver-Fay; Michael Tyka; Steven M Lewis; Oliver F Lange; James Thompson; Ron Jacak; Kristian Kaufman; P Douglas Renfrew; Colin A Smith; Will Sheffler; Ian W Davis; Seth Cooper; Adrien Treuille; Daniel J Mandell; Florian Richter; Yih-En Andrew Ban; Sarel J Fleishman; Jacob E Corn; David E Kim; Sergey Lyskov; Monica Berrondo; Stuart Mentzer; Zoran Popović; James J Havranek; John Karanicolas; Rhiju Das; Jens Meiler; Tanja Kortemme; Jeffrey J Gray; Brian Kuhlman; David Baker; Philip Bradley
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors.

Authors:  Ashok D Bandaranayake; Colin Correnti; Byoung Y Ryu; Michelle Brault; Roland K Strong; David J Rawlings
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

8.  Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence.

Authors:  Yariv Mazor; Kris F Sachsenmeier; Chunning Yang; Anna Hansen; Jessica Filderman; Kathy Mulgrew; Herren Wu; William F Dall'Acqua
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

9.  De novo design of bioactive protein switches.

Authors:  Robert A Langan; Scott E Boyken; Andrew H Ng; Jennifer A Samson; Galen Dods; Alexandra M Westbrook; Taylor H Nguyen; Marc J Lajoie; Zibo Chen; Stephanie Berger; Vikram Khipple Mulligan; John E Dueber; Walter R P Novak; Hana El-Samad; David Baker
Journal:  Nature       Date:  2019-07-24       Impact factor: 49.962

10.  MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.

Authors:  Ian W Davis; Andrew Leaver-Fay; Vincent B Chen; Jeremy N Block; Gary J Kapral; Xueyi Wang; Laura W Murray; W Bryan Arendall; Jack Snoeyink; Jane S Richardson; David C Richardson
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

View more
  25 in total

Review 1.  Design principles of protein switches.

Authors:  Robert G Alberstein; Amy B Guo; Tanja Kortemme
Journal:  Curr Opin Struct Biol       Date:  2021-09-16       Impact factor: 6.809

2.  Precise T cell recognition programs designed by transcriptionally linking multiple receptors.

Authors:  Jasper Z Williams; Greg M Allen; Devan Shah; Igal S Sterin; Ki H Kim; Vivian P Garcia; Gavin E Shavey; Wei Yu; Cristina Puig-Saus; Jennifer Tsoi; Antoni Ribas; Kole T Roybal; Wendell A Lim
Journal:  Science       Date:  2020-11-27       Impact factor: 47.728

Review 3.  Programmable protein circuit design.

Authors:  Zibo Chen; Michael B Elowitz
Journal:  Cell       Date:  2021-04-12       Impact factor: 41.582

Review 4.  Strategies for monitoring cell-cell interactions.

Authors:  Tyler J Bechtel; Tamara Reyes-Robles; Olugbeminiyi O Fadeyi; Rob C Oslund
Journal:  Nat Chem Biol       Date:  2021-05-25       Impact factor: 15.040

5.  De novo design of modular and tunable protein biosensors.

Authors:  Alfredo Quijano-Rubio; Hsien-Wei Yeh; Jooyoung Park; Hansol Lee; Robert A Langan; Scott E Boyken; Marc J Lajoie; Longxing Cao; Cameron M Chow; Marcos C Miranda; Jimin Wi; Hyo Jeong Hong; Lance Stewart; Byung-Ha Oh; David Baker
Journal:  Nature       Date:  2021-01-27       Impact factor: 49.962

Review 6.  Synthetic receptors for logic gated T cell recognition and function.

Authors:  Sylvain Simon; Grace Bugos; Alex I Salter; Stanley R Riddell
Journal:  Curr Opin Immunol       Date:  2021-09-24       Impact factor: 7.486

7.  A System for the Evolution of Protein-Protein Interaction Inducers.

Authors:  Jeffrey A Dewey; Saara-Anne Azizi; Vivian Lu; Bryan C Dickinson
Journal:  ACS Synth Biol       Date:  2021-07-28       Impact factor: 5.249

Review 8.  Genetic engineering of T cells for immunotherapy.

Authors:  Gavin I Ellis; Neil C Sheppard; James L Riley
Journal:  Nat Rev Genet       Date:  2021-02-18       Impact factor: 59.581

9.  The Art of Engineering Biomimetic Cellular Microenvironments.

Authors:  Ross C Bretherton; Cole A DeForest
Journal:  ACS Biomater Sci Eng       Date:  2021-02-01

Review 10.  The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control.

Authors:  Roberta Lucchi; Jordi Bentanachs; Benjamí Oller-Salvia
Journal:  ACS Cent Sci       Date:  2021-04-26       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.